Strategic partner Eli Lilly invested $15m while Pfizer, Ping An Ventures and Taiho Ventures also contributed to the immunotherapy developer's series B round.

Pfizer Ventures and 6 Dimensions Capital joined Merck & Co, Sanofi, Eli Lilly and Amgen in Kymera's series B round, taking the protein degradation drug developer's total funding to more than $95m.

LG, Sony, Munich Re, BNP Paribas and Denso have helped the mobility software developer reach a second close following a $28m first tranche in June.

Swisscom Ventures co-led the indoor drone developer's series B round, which also featured Dow Chemical and existing backers including MKS.

Boehringer Ingelheim and Helsinn helped University of Geneva vaccine spinout Amal reach the second close of a series B round that now totals $32.7m.

Memory technology supplier and New York University spinout Spin Memory has secured $52m in a round featuring Applied Ventures and Arm.

Osaka University and Kyoto Institute of Polymer Science have both put money behind automated patent investigation platform Gold IP, taking its funding to $4.6m altogether.

Memory technology supplier and New York University spinout Spin Memory has secured $52m in a round featuring Applied Ventures and Arm.

The e-commerce anti-fraud platform developer secured $14m in a CommerzVentures-led round that also featured Munich Re/HSB Ventures.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.